Matrix metalloproteinase-9 increases in the sputum from allergic occupational asthma patients after specific

Roberto Castano1, David Miedinger, Karim Maghni

  • 1Department of Surgery/Otolaryngology, Axe de recherche en santé respiratoire, Hôpital du Sacré-Coeur de Montréal, Montreal, Que., Canada. roberto.castano@umontreal.ca

Abstract

Insights

Occupational asthma triggered by flour inhalation increases sputum matrix metalloproteinase-9 (MMP-9) levels. This specific enzyme elevation is linked to lung function decline in sensitized patients.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Occupational Health

Background:

  • Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are implicated in asthma pathogenesis.
  • Elevated MMP-9 is observed in asthmatic patients' sputum post-allergen challenge.
  • The role of high-molecular-weight occupational allergens in MMP/TIMP modulation requires further investigation.

Purpose of the Study:

  • To investigate the impact of a high-molecular-weight occupational allergen (flour) on MMP-9 and other MMPs/TIMPs in occupational asthma.
  • To assess changes in lung function and sputum biomarkers following specific inhalation challenge (SIC).

Main Methods:

  • Ten patients with occupational asthma underwent a 2-day specific inhalation challenge (SIC) with flour.
  • Lung function (FEV1) was monitored for 7 hours post-challenge.
  • Induced sputum was analyzed for cell counts and levels of MMP-2, MMP-7, MMP-9, MMP-13, TIMP-1, and TIMP-2.

Main Results:

  • Flour challenge significantly increased eosinophils in sputum.
  • Sputum MMP-9 levels significantly increased post-flour challenge (p = 0.05).
  • MMP-9 levels showed a near-significant correlation with maximal FEV1 fall during asthmatic reactions (r = 0.67; p = 0.06).

Conclusions:

  • Specific inhalation challenge with flour increases MMP-9 in the sputum of sensitized occupational asthma patients.
  • MMP-9 elevation is a potential biomarker associated with flour-induced occupational asthma severity.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...